Barclays analyst Lauren Lieberman lowered the firm’s price target on Colgate-Palmolive (CL) to $82 from $87 and keeps an Equal Weight rating on the shares. The firm adjusted models to reflect “muted and decelerating” growth in parts of the personal care space since the Q2 reports.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive (CL) Strikes $332M Settlement in Pension Class-Action
- Colgate-Palmolive price target lowered to $90 from $100 at TD Cowen
- Strategic Initiatives and Financial Outlook Drive Buy Rating for Colgate-Palmolive
- Colgate-Palmolive price target lowered to $98 from $105 at BofA
- Colgate-Palmolive price target lowered to $96 from $104 at Morgan Stanley